These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 657151

  • 41. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI, Powell W.
    Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
    [Abstract] [Full Text] [Related]

  • 42. Cytosine arabinoside (NSC-63878)--clinical brochure.
    Livingston RB, Carter SK.
    Cancer Chemother Rep 3; 1968 Dec; 1(1):179-205. PubMed ID: 4989814
    [No Abstract] [Full Text] [Related]

  • 43. [Effect of daunorubicin and cytarabine on cell line NB4].
    Luo ZG, Zhong L, Chen FY, Wang HR, Ouyang RR.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202
    [Abstract] [Full Text] [Related]

  • 44. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
    Rose WC, Trader MW, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
    [No Abstract] [Full Text] [Related]

  • 45. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H.
    Ugeskr Laeger; 1972 Oct 16; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract] [Full Text] [Related]

  • 46. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
    Khanykova OK, Vinogorova GF.
    Antibiotiki; 1977 Sep 16; 22(9):846-52. PubMed ID: 911158
    [Abstract] [Full Text] [Related]

  • 47. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
    Tsukimoto I, Mimaya J, Toyosaka H, Nagao T, Hanawa Y.
    Rinsho Ketsueki; 1973 May 16; 14(5):596-603. PubMed ID: 4738276
    [No Abstract] [Full Text] [Related]

  • 48. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN, Herzig RH, Phillips GL, Lazarus HM, Greer JP, Stein RS, Ray WA, Herzig GP.
    Semin Oncol; 1987 Jun 16; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [Abstract] [Full Text] [Related]

  • 49. Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice.
    Kline I, Tyrer DD, Gang M, Venditti JM, Goldin A.
    Cancer Chemother Rep; 1968 Apr 16; 52(3):399-404. PubMed ID: 5670722
    [No Abstract] [Full Text] [Related]

  • 50. Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine.
    Valeriote F, Muntz ID, Vietti TJ.
    Invest New Drugs; 1985 Apr 16; 3(3):255-61. PubMed ID: 2415478
    [Abstract] [Full Text] [Related]

  • 51. Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-C.
    Hromas RA, Markel DE, Scholes VE.
    Res Commun Chem Pathol Pharmacol; 1980 Nov 16; 30(2):365-8. PubMed ID: 7444164
    [Abstract] [Full Text] [Related]

  • 52. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, vincristine and prednisolone (author's transl)].
    Yamaguchi H, Okabe N, Inoue A, Ichimaru M.
    Rinsho Ketsueki; 1975 Jun 16; 16(6):589-98. PubMed ID: 1172055
    [No Abstract] [Full Text] [Related]

  • 53. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI, Mitchell MS.
    J Natl Cancer Inst; 1982 Sep 16; 69(3):607-12. PubMed ID: 6981020
    [Abstract] [Full Text] [Related]

  • 54. [Chemotherapy with cytosine arabinoside, daunomycin and vincristine in refractory leukemia of childhood (author's transl)].
    Akatsuka J, Ueda Y, Ohmi K, Shike S, Nishimura K.
    Rinsho Ketsueki; 1975 Oct 16; 16(10):931-5. PubMed ID: 1239527
    [No Abstract] [Full Text] [Related]

  • 55. Acute myelocytic leukemia.
    Holland JF, Glidewell O, Ellison RR, Corey RW, Schwartz J, Wallace HJ, Hoagland HC, Wiernik P, Rai K, Bekesi JG, Cuttner J.
    Arch Intern Med; 1976 Dec 16; 136(12):1377-81. PubMed ID: 793552
    [No Abstract] [Full Text] [Related]

  • 56. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
    Li LH, Olin EJ, Buskirk HH, Reineke LM.
    Cancer Res; 1970 Nov 16; 30(11):2760-9. PubMed ID: 5487063
    [No Abstract] [Full Text] [Related]

  • 57. Progress in acute myelogenous leukemia.
    Gale RP.
    Cancer Treat Rep; 1981 Nov 16; 65 Suppl 4():87-92. PubMed ID: 7049383
    [Abstract] [Full Text] [Related]

  • 58. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A, Rinaldi CR, Palmieri S, Cantore N, Mele G, Mettivier V, Miraglia E, Mastrullo L, Grimaldi F, Luciano L, Guerriero A, Rotoli B, Ferrara F.
    Ann Hematol; 2009 Feb 16; 88(2):151-8. PubMed ID: 18709502
    [Abstract] [Full Text] [Related]

  • 59. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH, Calabresi P.
    J Natl Cancer Inst; 1972 Apr 16; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract] [Full Text] [Related]

  • 60. Cell-kill kinetics of several S-phase-specific drugs.
    Bhuyan BK, Fraser TJ, Gray LG, Kuentzel SL, Neil GL.
    Cancer Res; 1973 Apr 16; 33(4):888-94. PubMed ID: 4735241
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.